# Effects of Exercise in Combination With Epoetin Alfa

> **NCT00577096** · NA · COMPLETED · sponsor: **University of Arkansas** · enrollment: 120 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Epoetin Alfa
- **BEHAVIORAL:** Exercise
- **BIOLOGICAL:** Autologous Peripheral Blood Stem Cell Transplantation
- **BIOLOGICAL:** Red Blood Cell Transfusion
- **DRUG:** Thalidomide
- **DRUG:** Heparin, Low-Molecular-Weight
- **BIOLOGICAL:** Platelet Transfusion
- **DRUG:** Melphalan
- **DRUG:** Epoetin Alfa
- **DRUG:** Total Therapy II
- **BIOLOGICAL:** Red Blood Cell Transfusion
- **DRUG:** Thalidomide
- **DRUG:** Heparin, Low-Molecular-Weight
- **BIOLOGICAL:** Platelet Transfusion
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT00577096
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577096, "Effects of Exercise in Combination With Epoetin Alfa". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00577096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*